Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors
July 01, 2021 at 01:05 pm
Avid Bioservices, Inc. announced the appointment of Esther M. Alegria, Ph.D., as an independent member of the company’s board of directors. Dr. Alegria has nearly 30 years of biopharmaceutical industry experience spanning research and development, manufacturing, quality control, assurance and compliance, technology transfer and regulatory submissions supporting the development and commercialization of small and large molecule therapeutics and vaccines. Dr. Alegria currently serves as the chief executive officer of APIE Therapeutics.